Antidepressant-like effect by postsynaptic 5-HT1A receptor activation in mice. 1995

T Matsuda, and P Somboonthum, and M Suzuki, and S Asano, and A Baba
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Osaka University, Japan.

The antidepressant-like effect of 5-(3(-)[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy)-1,3- benzodioxole (MKC-242), a novel 5-HT1A receptor agonist, was studied in the forced swimming test in mice injected i.c.v. with 5,7-dihydroxytryptamine to destroy 5-HT neurons or treated with p-chlorophenylalanine to inhibit 5-HT synthesis. MKC-242 reduced immobility time of mice pretreated with vehicle and these drugs, although it did not affect their locomotor activity. The anti-immobility effect was antagonized by 5-HT1A receptor antagonists such as propranolol and N-tert-butyl-3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-phenylpropana mide. These findings support the hypothesis that postsynaptic 5-HT1A receptors play an important role in the antidepressant-like effect of 5-HT1A receptor agonists.

UI MeSH Term Description Entries
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010134 Fenclonine A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin. p-Chlorophenylalanine,para-Chlorophenylalanine,CP-10,188,DL-3-(4-Chlorophenyl)alanine,Fenclonin,Fenclonine (L)-Isomer,Fenclonine Hydrobromide,Fenclonine Hydrochloride,Fenclonine, (D)-Isomer,Hydrobromide, Fenclonine,Hydrochloride, Fenclonine,para Chlorophenylalanine
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004146 Dioxanes Compounds that contain the structure 1,4-dioxane.
D004149 Dioxoles
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D013550 Swimming An activity in which the body is propelled through water by specific movement of the arms and/or the legs. Swimming as propulsion through water by the movement of limbs, tail, or fins of animals is often studied as a form of PHYSICAL EXERTION or endurance.

Related Publications

T Matsuda, and P Somboonthum, and M Suzuki, and S Asano, and A Baba
March 1993, British journal of pharmacology,
T Matsuda, and P Somboonthum, and M Suzuki, and S Asano, and A Baba
July 2015, Scientific reports,
T Matsuda, and P Somboonthum, and M Suzuki, and S Asano, and A Baba
May 1997, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
T Matsuda, and P Somboonthum, and M Suzuki, and S Asano, and A Baba
June 1987, European journal of pharmacology,
T Matsuda, and P Somboonthum, and M Suzuki, and S Asano, and A Baba
January 2005, European journal of pharmacology,
T Matsuda, and P Somboonthum, and M Suzuki, and S Asano, and A Baba
December 1998, Proceedings of the National Academy of Sciences of the United States of America,
T Matsuda, and P Somboonthum, and M Suzuki, and S Asano, and A Baba
July 1992, British journal of pharmacology,
T Matsuda, and P Somboonthum, and M Suzuki, and S Asano, and A Baba
March 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
T Matsuda, and P Somboonthum, and M Suzuki, and S Asano, and A Baba
May 2001, European journal of pharmacology,
T Matsuda, and P Somboonthum, and M Suzuki, and S Asano, and A Baba
June 2013, Brain research bulletin,
Copied contents to your clipboard!